Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

How to study political activists: A petition survey approach.

Durso R, Craig Jenkins J, Martin A, Stearmer M.

Soc Sci Res. 2018 Jul;73:207-220. doi: 10.1016/j.ssresearch.2018.03.014. Epub 2018 Mar 27.

PMID:
29793687
2.

Impacts of religious semantic priming on an intertemporal discounting task: Response time effects and neural correlates.

Morgan J, Clark D, Tripodis Y, Halloran CS, Minsky A, Wildman WJ, Durso R, McNamara P.

Neuropsychologia. 2016 Aug;89:403-413. doi: 10.1016/j.neuropsychologia.2016.07.020. Epub 2016 Jul 20.

PMID:
27450269
3.

A potential case of remission of Parkinson's disease.

Smart K, Durso R, Morgan J, McNamara P.

J Complement Integr Med. 2016 Sep 1;13(3):311-315. doi: 10.1515/jcim-2016-0019.

PMID:
27379905
4.

Possible selves in patients with right- versus left-onset Parkinson's disease.

Harris E, McNamara P, Durso R.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2017 Mar;24(2):198-215. doi: 10.1080/13825585.2016.1178211. Epub 2016 May 4.

PMID:
27141970
5.

Younger age at onset of sporadic Parkinson's disease among subjects occupationally exposed to metals and pesticides.

Ratner MH, Farb DH, Ozer J, Feldman RG, Durso R.

Interdiscip Toxicol. 2014 Sep;7(3):123-33. doi: 10.2478/intox-2014-0017. Epub 2014 Dec 30.

6.

Novelty seeking in patients with right- versus left-onset Parkinson disease.

Harris E, McNamara P, Durso R.

Cogn Behav Neurol. 2015 Mar;28(1):11-6. doi: 10.1097/WNN.0000000000000047.

PMID:
25812126
7.

Apathy in patients with Parkinson disease as a function of side of onset.

Harris E, McNamara P, Durso R.

J Geriatr Psychiatry Neurol. 2013 Jun;26(2):95-104. doi: 10.1177/0891988713481267. Epub 2013 Apr 12.

PMID:
23584852
8.

Partnership among a faith-based organization and community.

Aponte J, Cruz H, Arce S, Durso RM.

Holist Nurs Pract. 2013 May-Jun;27(3):162-7. doi: 10.1097/HNP.0b013e31828a099a.

PMID:
23580102
9.

A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer.

Slovin SF, Kehoe M, Durso R, Fernandez C, Olson W, Gao JP, Israel R, Scher HI, Morris S.

Vaccine. 2013 Jan 30;31(6):943-9. doi: 10.1016/j.vaccine.2012.11.096. Epub 2012 Dec 13.

PMID:
23246260
11.

Disease-associated differences in religious cognition in patients with Parkinson's disease.

Butler PM, McNamara P, Ghofrani J, Durso R.

J Clin Exp Neuropsychol. 2011 Oct;33(8):917-28. doi: 10.1080/13803395.2011.575768. Epub 2011 Jun 28.

PMID:
21656414
12.

Side of onset in Parkinson's disease and alterations in religiosity: novel behavioral phenotypes.

Butler PM, McNamara P, Durso R.

Behav Neurol. 2011;24(2):133-41. doi: 10.3233/BEN-2011-0282.

13.

The Impact of Clinical and Cognitive Variables on Social Functioning in Parkinson's Disease: Patient versus Examiner Estimates.

McNamara P, Stavitsky K, Durso R, Harris E.

Parkinsons Dis. 2010 Mar 11;2010. pii: 263083. doi: 10.4061/2010/263083.

14.

Social cognition of indirect speech: Evidence from Parkinson's Disease.

McNamara P, Holtgraves T, Durso R, Harris E.

J Neurolinguistics. 2010 Mar 1;23(2):162.

15.

Deficits in the automatic activation of religious concepts in patients with Parkinson's disease.

Butler PM, McNamara P, Durso R.

J Int Neuropsychol Soc. 2010 Mar;16(2):252-61. doi: 10.1017/S1355617709991202. Epub 2009 Dec 4.

PMID:
19958570
16.

Linguistic correlates of asymmetric motor symptom severity in Parkinson's Disease.

Holtgraves T, McNamara P, Cappaert K, Durso R.

Brain Cogn. 2010 Mar;72(2):189-96. doi: 10.1016/j.bandc.2009.08.004. Epub 2009 Sep 13.

17.

Mood, side of motor symptom onset and pain complaints in Parkinson's disease.

McNamara P, Stavitsky K, Harris E, Szent-Imrey O, Durso R.

Int J Geriatr Psychiatry. 2010 May;25(5):519-24. doi: 10.1002/gps.2374.

PMID:
19711336
18.

Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1.

Kang YK, Andjelic S, Binley JM, Crooks ET, Franti M, Iyer SP, Donovan GP, Dey AK, Zhu P, Roux KH, Durso RJ, Parsons TF, Maddon PJ, Moore JP, Olson WC.

Vaccine. 2009 Aug 13;27(37):5120-32. doi: 10.1016/j.vaccine.2009.06.037. Epub 2009 Jun 28.

19.

Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo.

Banerjee K, Andjelic S, Klasse PJ, Kang Y, Sanders RW, Michael E, Durso RJ, Ketas TJ, Olson WC, Moore JP.

Virology. 2009 Jun 20;389(1-2):108-21. doi: 10.1016/j.virol.2009.04.001. Epub 2009 May 2.

20.

Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks.

Stavitsky K, McNamara P, Durso R, Harris E, Auerbach S, Cronin-Golomb A.

Cogn Behav Neurol. 2008 Sep;21(3):143-9. doi: 10.1097/WNN.0b013e318185e698.

21.

A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses.

Durso RJ, Andjelic S, Gardner JP, Margitich DJ, Donovan GP, Arrigale RR, Wang X, Maughan MF, Talarico TL, Olmsted RA, Heston WD, Maddon PJ, Olson WC.

Clin Cancer Res. 2007 Jul 1;13(13):3999-4008.

22.

Alterations of the sense of self and personality in Parkinson's disease.

McNamara P, Durso R, Harris E.

Int J Geriatr Psychiatry. 2008 Jan;23(1):79-84.

PMID:
17562520
23.

"Machiavellianism" and frontal dysfunction: evidence from Parkinson's disease.

McNamara P, Durso R, Harris E.

Cogn Neuropsychiatry. 2007 Jul;12(4):285-300.

PMID:
17558639
24.
25.

Religiosity in patients with Parkinson's disease.

McNamara P, Durso R, Brown A.

Neuropsychiatr Dis Treat. 2006 Sep;2(3):341-8.

26.

L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticles.

Falkowska E, Durso RJ, Gardner JP, Cormier EG, Arrigale RA, Ogawa RN, Donovan GP, Maddon PJ, Olson WC, Dragic T.

J Gen Virol. 2006 Sep;87(Pt 9):2571-6.

PMID:
16894195
27.

Neuropharmacological treatment of mental dysfunction in Parkinson's disease.

McNamara P, Durso R.

Behav Neurol. 2006;17(1):43-51. Review.

28.

Correlates of excessive daytime sleepiness in Parkinson's disease.

Wegelin J, McNamara P, Durso R, Brown A, McLaren D.

Parkinsonism Relat Disord. 2005 Nov;11(7):441-8. Epub 2005 Sep 9.

PMID:
16154796
29.

Reversible withdrawal dyskinesia associated with quetiapine.

Michaelides C, Thakore-James M, Durso R.

Mov Disord. 2005 Jun;20(6):769-70. No abstract available.

PMID:
15747370
30.

L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus.

Cormier EG, Durso RJ, Tsamis F, Boussemart L, Manix C, Olson WC, Gardner JP, Dragic T.

Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14067-72. Epub 2004 Sep 15.

31.

CD81 is an entry coreceptor for hepatitis C virus.

Cormier EG, Tsamis F, Kajumo F, Durso RJ, Gardner JP, Dragic T.

Proc Natl Acad Sci U S A. 2004 May 11;101(19):7270-4. Epub 2004 May 3.

32.

Relation of "Sense Of Self" to executive function performance in Parkinson's disease.

McNamara P, Durso R, Brown A.

Cogn Behav Neurol. 2003 Sep;16(3):139-48.

PMID:
14501535
33.

Counterfactual cognitive deficit in persons with Parkinson's disease.

McNamara P, Durso R, Brown A, Lynch A.

J Neurol Neurosurg Psychiatry. 2003 Aug;74(8):1065-70.

34.

L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus.

Gardner JP, Durso RJ, Arrigale RR, Donovan GP, Maddon PJ, Dragic T, Olson WC.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4498-503. Epub 2003 Apr 3.

35.

Pragmatic communication skills in patients with Parkinson's disease.

McNamara P, Durso R.

Brain Lang. 2003 Mar;84(3):414-23.

PMID:
12662979
36.

Analysis of TAF90 mutants displaying allele-specific and broad defects in transcription.

Durso RJ, Fisher AK, Albright-Frey TJ, Reese JC.

Mol Cell Biol. 2001 Nov;21(21):7331-44.

37.
38.

Variable absorption of carbidopa affects both peripheral and central levodopa metabolism.

Durso R, Evans JE, Josephs E, Szabo G, Evans B, Fernandez HH, Browne TR.

J Clin Pharmacol. 2000 Aug;40(8):854-60.

PMID:
10934669
39.

Clozapine for dopaminergic-induced paraphilias in Parkinson's disease.

Fernandez HH, Durso R.

Mov Disord. 1998 May;13(3):597-8. No abstract available.

PMID:
9613761
40.

Central levodopa metabolism in Parkinson's disease after administration of stable isotope-labeled levodopa.

Durso R, Evans JE, Josephs E, Szabo GK, Evans BA, Handler JS, Jennings D, Browne TR.

Ann Neurol. 1997 Sep;42(3):300-4.

PMID:
9307250
41.

A comparison of NES2 and traditional neuropsychological tests in a neurologic patient sample.

Krengel M, White RF, Diamond R, Letz R, Cyrus P, Durso R.

Neurotoxicol Teratol. 1996 Jul-Aug;18(4):435-9.

PMID:
8866535
42.

Grammaticality judgments and sentence comprehension in Parkinson's disease: a comparison with Broca's aphasia.

McNamara P, Krueger M, O'Quin K, Clark J, Durso R.

Int J Neurosci. 1996 Jul;86(1-2):151-66.

PMID:
8828068
44.

Age influences magnitude but not duration of response to levodopa.

Durso R, Isaac K, Perry L, Saint-Hilaire M, Feldman RG.

J Neurol Neurosurg Psychiatry. 1993 Jan;56(1):65-8.

45.

Speech monitoring skills in Alzheimer's disease, Parkinson's disease, and normal aging.

McNamara P, Obler LK, Au R, Durso R, Albert ML.

Brain Lang. 1992 Jan;42(1):38-51.

PMID:
1547468
46.

Reversible pathologic jealousy (Othello syndrome) associated with amantadine.

McNamara P, Durso R.

J Geriatr Psychiatry Neurol. 1991 Jul-Sep;4(3):157-9.

PMID:
1953968
47.

Neuropsychological profile linked to low dopamine: in Alzheimer's disease, major depression, and Parkinson's disease.

Wolfe N, Katz DI, Albert ML, Almozlino A, Durso R, Smith MC, Volicer L.

J Neurol Neurosurg Psychiatry. 1990 Oct;53(10):915-7.

48.

GM1 gangliosides alter acute MPTP-induced behavioral and neurochemical toxicity in mice.

Fazzini E, Durso R, Davoudi H, Szabo GK, Albert ML.

J Neurol Sci. 1990 Oct;99(1):59-68.

PMID:
2250172
49.
50.

Alpha-melanocyte-stimulating hormonelike immunoreactivity is increased in cerebrospinal fluid of patients with Parkinson's disease.

Rainero I, Kaye JA, May C, Durso R, Katz DI, Albert ML, Wolfe N, Pinessi L, Friedland RP, Rapoport SI.

Arch Neurol. 1988 Nov;45(11):1224-7.

PMID:
2847695

Supplemental Content

Support Center